#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14380	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2137	669.1	0	.	n	.	0	C451T	SNP	451	451	C	737	737	T	841	T,C	611,182	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14380	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2137	669.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1470	1470	C	892	C	840	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14380	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2137	669.1	0	HET	.	.	.	C207T,G	.	207	207	C	493	493	C	796	C,T,G	594,146,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14380	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2137	669.1	0	HET	.	.	.	C1450T	.	1450	1450	C	1736	1736	C	807	C,T	596,171	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26522	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3552	743.9	0	.	n	.	0	T695C	SNP	695	695	T	1087	1087	C	886	C	826	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26522	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3552	743.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2363	2363	C	869	C	817	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26522	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3552	743.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2437	2437	A	866	A	812	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26522	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3552	743.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2989	2989	C	787	C,A	730,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1958	folP	855	855	100.0	folP.l15.c4.ctg.1	1440	135.0	1	SNP	p	R229S	1	.	.	685	687	AGC	971	973	AGC	209;207;209	A,G;G;C	196,1;195;195	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5158	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3366	152.8	1	SNP	p	S91F	1	.	.	271	273	TTC	546	548	TTC	178;178;179	T;T;C	165;168;167	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5158	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3366	152.8	1	SNP	p	G95N	0	.	.	283	285	GGC	558	560	GGC	181;182;183	G;G;C	171;172;172	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5158	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3366	152.8	1	SNP	p	D95G	1	.	.	283	285	GGC	558	560	GGC	181;182;183	G;G;C	171;172;172	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1642	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1309	125.0	1	SNP	p	G45D	0	.	.	133	135	GGC	442	444	GGC	227;224;222	G,T;G,A;C	211,1;205,1;206	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	868	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	936	92.3	0	.	n	.	0	A197.	DEL	197	197	A	548	548	A	213	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4894	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2958	165.2	1	SNP	p	D86N	0	.	.	256	258	GAC	550	552	GAC	174;174;175	G;A;C	160;163;165	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4894	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2958	165.2	1	SNP	p	S87R	1	.	.	259	261	CGT	553	555	CGT	176;178;179	C;G,A;T	164;163,1;168	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4894	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2958	165.2	1	SNP	p	R87W	0	.	.	259	261	CGT	553	555	CGT	176;178;179	C;G,A;T	164;163,1;168	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4894	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2958	165.2	1	SNP	p	R87I	0	.	.	259	261	CGT	553	555	CGT	176;178;179	C;G,A;T	164;163,1;168	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4894	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2958	165.2	1	SNP	p	S88P	0	.	.	262	264	TCC	556	558	TCC	183;186;182	T;C;C	172;173;171	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3998	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2565	155.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1491	1493	GGC	184;181;179	G;G;C	165;161;158	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1152	1154	GCC	222;224;223	G;C;C	211;212;212	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1155	1157	ATG	220;221;218	A;T;G	210;210;207	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1167	1169	ACC	212;213;213	A;C;C	206;207;207	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1167	1169	ACC	212;213;213	A;C;C	206;207;207	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1668	1670	ACC	207;209;211	A;C;C	191;192;193	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1722	1724	GCG	202;201;203	G;C;G	187;189;189	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1722	1724	GCG	202;201;203	G;C;G	187;189;189	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1845	1847	GGT	122;120;123	G;G;T	112;110;108	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1854	1856	AGC	119;121;120	A;G;C	105;106;107	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3904	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2275	170.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1872	1874	CCG	107;110;111	C,G;C,G;G	81,6;85,1;85	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5614	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3113	179.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1654	1656	CCG	206;202;204	C;C;G	186;192;194	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2160	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1699	125.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	431	431	C	158	C	146	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	309	90.73	porB1a.l15.c30.ctg.2	371	26.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	84	86	AAT	18;18;18	A;A;T	18;18;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	309	90.73	porB1a.l15.c30.ctg.2	371	26.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	87	89	AAT	18;18;18	A;A;T	18;18;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	309	90.73	porB1a.l15.c30.ctg.2	371	26.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	111	113	GCA	15;15;15	G;C;A	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	309	90.73	porB1a.l15.c30.ctg.2	371	26.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	134	136	GTA	13;13;13	G;T;A	12;12;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	248	porB1a	984	309	90.73	porB1a.l15.c30.ctg.2	371	26.7	0	.	p	.	0	N237fs	FSHIFT	709	709	A	143	143	A	13	A	13	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	459	461	GTT	209;209;211	G;T;T	200;197;202	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	G48A	NONSYN	142	144	GGA	468	470	GCA	222;223;224	G;C,G;A	207;205,1;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	I75V	NONSYN	223	225	ATT	549	551	GTT	223;222;227	G,A;T;T	202,1;193;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	S89T	NONSYN	265	267	AGC	591	593	ACC	208;208;208	A;C,G;C	188;190,1;194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	I98V	NONSYN	292	294	ATC	618	620	GTC	215;217;214	G,A;T;C	202,1;204;203	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	A109V	NONSYN	325	327	GCC	651	653	GTC	210;210;210	G;T;C	198;194;200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	717	719	TAT	216;212;214	T;A;T	202;198;200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	N134E	NONSYN	400	402	AAT	726	728	GAG	209;211;211	G;A;G	196;198;196	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	V135L	NONSYN	403	405	GTG	729	731	CTT	209;210;209	C;T;T	191;194;194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	G140K	NONSYN	418	420	GGA	744	746	AAA	195;198;195	A;A;A	182;185;181	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	Q143G	NONSYN	427	429	CAA	753	755	GGA	196;197;195	G;G;A	182;182;179	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2708	porB1b	1038	1038	97.5	porB1b.l6.c4.ctg.1	1576	171.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	777	779	GCA	200;198;197	G;C;A	188;185;182	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10206	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4882	208.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1208	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1016	118.3	1	SNP	p	V57M	1	.	.	169	171	ATG	471	473	ATG	239;240;238	A;T;G	230;230;226	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
